Orchid receives US FDA approval for Cefuroxime
New Delhi, Feb 20 (UNI) Orchid Chemicals&Pharmaceuticals Ltd today said it has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for Cefuroxime Axetil Tablets.
The product is available in three dosage strengths, 125 mg, 250 mg and 500 mg, said a statement.
This is the 25th ANDA approval that the Company has received since it started its US Generics journey in 2005.
UNI PBB RL SSC1157
More From
-
Gold Silver Rate Today, 10 March 2026: City-Wise Prices Edge Lower While MCX Gold And Silver Stay Range-Bound -
Hyderabad To Get Faster Road Link To Indore As New Highway Nears Completion, Opening Likely This Month -
Hyderabad Gold Silver Rate Today, 10 March 2026: Gold, Silver Slip In Local Market; MCX Also Trades Lower -
Oil Slumps 6% As Trump Claims Iran War Will Be Over 'Ahead of Schedule' -
Pune Gold Rate Today For 18K, 22K, 24K For Rates March 2026 -
Bangalore Gold Silver Rate Today, March 10, 2026: Gold and Silver Prices Go Up -
IPL 2026 Schedule Announcement On March 12: BCCI to Release First 20 Days of Indian Premier League Fixtures -
IPL 2026 Playing XI Prediction: CSK, MI, RCB, KKR, PBKS, GT, LSG, DC, RR, SRH Impact Sub & Full Team List -
Chennai Hotels Warn of Shutdown In 2 Days As LPG Supply Crunch Hits TN -
Trisha Shouldn't Have Attended The Event With Vijay: Parthiban -
Pakistan Facing Oil Crisis? PM Orders Shutdown Of Schools And Universities, Introduces 4-Day Workweek -
Flight Ticket Prices To Turn Costly Due To Iran Crisis? SpiceJet Chief Hints At Airfare Hike
Click it and Unblock the Notifications
Sign in with Google